Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis
Fig 2
Effect of length of stay (LOS) in prison (2 months LOS (a,b), 6 months LOS (c,d), 24 months LOS (e,f), 36 months LOS (g,h)) and treatment coverage (blue lines: 10% DAA, red lines: 25% DAA, orange lines: 50% DAA, purple lines: 90% DAA) on the incidence (per 100 py) and prevalence of chronic HCV in prison.